Advertisement

Advertisement

2016 ASH Annual Meeting

Advertisement

Advertisement



Jun
27
Today In Oncology
15-ICML: Post Hoc Analysis of MAVORIC Study: Mogamulizumab in Patients With Previously Treated Cutaneous T-Cell Lymphoma
15-ICML: Identifying Genetic Alterations Associated With Relapse in DLBCL
Transition to Outpatient Infusional EPOCH-Based Chemotherapy at a Safety Net Hospital
Activity of Nivolumab for Renal Cell Carcinoma Brain Metastases
Does Adjuvant Chemoradiotherapy Extend Relapse-Free Survival in Stage III or IVA Endometrial Cancer?
View More 
;
Advertisement
Most Read Stories
EHA 2019: ASCEND Trial Compares Acalabrutinib vs Investigator’s Choice in Relapsed or Refractory CLL
FDA Expands Indications for Pembrolizumab to Include Metastatic SCLC With Disease Progression on or After Other Therapies
2019 ASCO: 3-Year Outcomes in the KRISTINE Trial on Neoadjuvant Trastuzumab Emtansine Plus Pertuzumab in HER2-Positive Breast Cancer
EHA 2019: CLL12 Trial Investigates Ibrutinib in Previously Untreated, Asymptomatic Early-Stage CLL
When Can Patients With Gleason 6 Prostate Cancer Safely Undergo Active Surveillance?
View More 
Most Viewed Videos
Margaret A. Tempero, MD, on Pancreatic Cancer: Adjuvant Nab-paclitaxel and Gemcitabine
Thomas J. George, MD, on Locally Advanced Rectal Cancer: Total Neoadjuvant Therapy
Jason Westin, MD, on Diffuse Large B-Cell Lymphoma: Rituximab, Lenalidomide, and Ibrutinib Prior to Chemotherapy
Suleika Jaouad on Making the Most of a Life Interrupted: A Young Adult Perspective on Cancer
Kim N. Chi, MD, on Castration-Resistant Prostate Cancer: Cabazitaxel vs Abiraterone or Enzalutamide in the Metastatic Setting
View More 
© 2019 HSP News Service, L.L.C.